Filing Details
- Accession Number:
- 0001062993-14-003536
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-03 16:43:42
- Reporting Period:
- 2014-05-30
- Filing Date:
- 2014-06-03
- Accepted Time:
- 2014-06-03 16:43:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875622 | Biospecifics Technologies Corp | BSTC | Pharmaceutical Preparations (2834) | 113054851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1375327 | Henry Morgan | Po Box 499, 11 Dogwood Road Hope NJ 07844 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Disposition | 2014-05-30 | 337 | $27.02 | 36,856 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2014-06-02 | 800 | $27.03 | 36,056 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2014-06-02 | 923 | $27.00 | 35,133 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The selling price of $27.0218 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $27.00 to $27.05. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The selling price of $27.0262 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $27.00 to $27.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
